FDA applicant
Brahms Aktiengesellschaft
FDA records 2 decisions for Brahms Aktiengesellschaft (Beltsville, MD) from 2005 to 2008: 2 510(k) clearances. All are in product code NTM (Antigen, Inflammatory Response Marker, Sepsis). Its devices cite 2 predicates, 1 of them its own earlier devices. No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Brahms Aktiengesellschaft’s devices, and how often a recall has named them.
FDA decisions per year
1in 2008
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2007.
Planning a device like Brahms Aktiengesellschaft’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Brahms”
FDA records each applicant name separately; these may or may not be the same firm.